文献速递妇科产科

Pap涂片DNA中TP53突变特征在浆液性卵巢癌诊断中的探索

Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma.
PubMed 文献 · Gynecol Oncol · 2019-12-12

研究采用CRISPR-DS超深度测序(平均双链深度约3000×)分析30例Pap涂片(21例无癌女性,9例浆液性卵巢癌且已知TP53驱动突变)的TP53基因。结果显示,8例输卵管完整的卵巢癌患者中仅3例检出肿瘤源性突变;共鉴定221个低频(≲0.001)外显子TP53突变,其中卵巢癌组94个、无癌组127个,许多突变类似癌症中的TP53突变。结论认为Pap涂片对卵巢癌检测敏感性低,但携带大量低频TP53突变,且卵巢癌女性中致病性突变频率更高。

要点

  • Pap涂片检测卵巢癌敏感性有限:8例输卵管完整的卵巢癌患者中仅3例检出肿瘤源性突变。
  • Pap涂片携带大量低频TP53突变,卵巢癌组94个、无癌组127个,多位于外显子5-8和热点密码子。
  • 癌症样TP53突变在所有女性中均存在,但在卵巢癌女性中频率更高。

核心结论

  • Pap涂片对卵巢癌检测敏感性低,且携带丰富的低频TP53突变;这些突变在卵巢癌女性中更常具有致病性。

研究设计与样本

  • 研究采用CRISPR-DS对30例Pap涂片(21例无癌女性,9例浆液性卵巢癌且已知TP53驱动突变)的TP53基因进行超深度测序,平均双链深度约3000×。

主要发现

  • 8例输卵管完整的卵巢癌患者中,3例Pap涂片检出肿瘤源性突变。
  • 共鉴定221个低频(≲0.001)外显子TP53突变:卵巢癌组94个,无癌组127个。
  • 许多低频突变类似癌症中的TP53突变,可损害蛋白活性、预测为致病性、聚集于外显子5-8和热点密码子。
  • 癌症样突变在所有女性中均检出,但在卵巢癌女性中频率更高。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pap tests hold promise as a molecular diagnostic for serous ovarian cancer, but previous studies reported limited sensitivity. Furthermore, the presence of somatic mutations in normal tissue is increasingly recognized as a challenge to the specificity of mutation-based cancer diagnostics. We applied an ultra-deep sequencing method with the goal of improving sensitivity and characterizing the landscape of low-frequency somatic TP53 mutations in Pap tests. METHODS: We used CRISPR-DS to deeply sequence (mean Duplex depth ~3000×) the TP53 gene in 30 Pap tests from 21 women without cancer and 9 women with serous ovarian carcinoma with known TP53 driver mutations. Mutations were annotated and compared to those in the TP53 cancer database. RESULTS: The tumor-derived mutation was identified in 3 of 8 Pap tests from women with ovarian cancer and intact tubes. In addition, 221 low-frequency (≲0.001) exonic TP53 mutations were identified in Pap tests from women with ovarian cancer (94 mutations) and without ovarian cancer (127 mutations). Many of these mutations resembled TP53 mutations found in cancer: they impaired protein activity, were predicted to be pathogenic, and clustered in exons 5 to 8 and hotspot codons. Cancer-like mutations were identified in all women but at higher frequency in women with ovarian cancer. CONCLUSIONS: Pap tests have low sensitivity for ovarian cancer detection and carry abundant low-frequency TP53 mutations. These mutations are more frequently pathogenic in women with ovarian cancer. Determining whether low-frequency TP53 mutations in normal gynecologic tissues are associated with an increased cancer risk warrants further study.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Krimmel-Morrison JD, Ghezelayagh TS, Lian S, et al. Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma. Gynecol Oncol. 2019. PMID: 31839337. doi:10.1016/j.ygyno.2019.11.124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。